This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Glutamatergic dysfunction in Schizophrenia
Translational Psychiatry Open Access 03 December 2022
-
The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans
Psychopharmacology Open Access 19 November 2022
-
Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia
Molecular Psychiatry Open Access 14 April 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al. Arch Gen Psychiatry 1994; 51: 199–214.
Moghaddam B, Adams B, Verma A, Daly D . J Neurosci 1997; 17: 2921–2927.
Kim SY, Lee H, Kim HJ, Bang E, Lee SH, Lee DW et al. NMR Biomed 2011; doi:10.1002/nbm.1681, PMID 21560175 (e-pub ahead of print).
Rowland LM, Bustillo JR, Mullins PG, Jung RE, Lenroot R, Landgraf E et al. Am J Psychiatry 2005; 162: 394–396.
Homayoun H, Moghaddam B . J Neurosci 2007; 27: 11496–11500.
Farber NB, Jiang X, Dikranian K, Nemmers B . Brain Res 2003; 993: 90–100.
Valentine GW, Mason GF, Gomez R, Fasula M, Watzl J, Pittman B et al. Psychiatry Res 2011; 191: 122–127.
Stone JM, Day F, Tsagaraki H, Valli I, McLean MA, Lythgoe DJ et al. Biol Psychiatry 2009; 66: 533–539.
Théberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J et al. Am J Psychiatry 2002; 159: 1944–1946.
Luykx JJ, Laban KG, van den Heuvel MP, Boks MP, Mandl RC, Kahn RS et al. Neurosci Biobehav Rev 2012; 36: 198–205.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
PowerPoint slides
Rights and permissions
About this article
Cite this article
Stone, J., Dietrich, C., Edden, R. et al. Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology. Mol Psychiatry 17, 664–665 (2012). https://doi.org/10.1038/mp.2011.171
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2011.171
This article is cited by
-
Longitudinal changes in brain metabolites in healthy controls and patients with first episode psychosis: a 7-Tesla MRS study
Molecular Psychiatry (2023)
-
Association of default-mode network neurotransmitters and inter-network functional connectivity in first episode psychosis
Neuropsychopharmacology (2023)
-
Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia
Molecular Psychiatry (2022)
-
Glutamatergic dysfunction in Schizophrenia
Translational Psychiatry (2022)
-
Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism
European Archives of Psychiatry and Clinical Neuroscience (2022)